Amitriptyline plasma level and its possible correlation with cognitive impairment and driving performance in migraine patients; pilot study

被引：0
|
作者：
Bellamio, Matteo [1 ]
Mainardi, Federico [2 ]
Barp, Michele [3 ]
Terrin, Alberto [3 ]
Zanchin, Giorgio [3 ]
Maggioni, Ferdinando [3 ]
机构：
[1] Angelo Hosp, Neurol Div, Headache Ctr, I-30121 Venice, VE, Italy
[2] SS Giovanni Paolo Hosp, Neurol Div, Headache Ctr, Venice, Italy
[3] Univ Padua, Dept Neurosci, Headache Ctr, Padua, Italy
来源：
JOURNAL OF HEADACHE AND PAIN | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P195
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study
    Alana C. Costa
    Helena P. G. Joaquim
    Orestes V. Forlenza
    Wagner F. Gattaz
    Leda L. Talib
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 483 - 488
  • [22] Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients
    Singh, Pradeep K.
    Chen, Zu-Lin
    Ghosh, Dhiman
    Strickland, Sidney
    Norris, Erin H.
    NEUROBIOLOGY OF DISEASE, 2020, 139
  • [23] A pilot study to evaluate simulated driving performance and cognitive function in healthy subjects and patients with restless legs syndrome
    Chen, Dan
    Shaw, Paula
    Canafax, Daniel M.
    Ware, James Catesby
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2013, 3 : 53 - 62
  • [24] Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
    Wang, Hua
    Atik, Anzari
    Stewart, Tessandra
    Ginghina, Carmen
    Aro, Patrick
    Kerr, Kathleen F.
    Seibyl, John
    Jennings, Danna
    Jensen, Poul Henning
    Marek, Kenneth
    Shi, Min
    Zhang, Jing
    NEUROBIOLOGY OF DISEASE, 2018, 116 : 53 - 59
  • [25] A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA)
    Wu, Caili
    Dagg, Paul
    Molgat, Carmen
    SCHIZOPHRENIA RESEARCH, 2014, 158 (1-3) : 151 - 155
  • [26] Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study
    Bar-Sela, Gil
    Tauber, Dina
    Mitnik, Inbal
    Sheinman-Yuffe, Hedva
    Bishara-Frolova, Tatiana
    Aharon-Peretz, Judith
    ANTI-CANCER DRUGS, 2019, 30 (01) : 91 - 97
  • [27] Benefits of pulmonary rehabilitation in COPD patients with mild cognitive impairment - A pilot study
    Andrianopoulos, Vasileios
    Gloeckl, Rainer
    Schneeberger, Tessa
    Jarosch, Inga
    Vogiatzis, Ioannis
    Hume, Emily
    Koczulla, Rembert A.
    Kenn, Klaus
    RESPIRATORY MEDICINE, 2021, 185
  • [28] Changes in cognitive impairment in ovarian cancer patients receiving chemotherapy; a pilot study
    Szabo, M.
    Heller, N.
    Gallanagh, M.
    Nussey, F.
    Gourley, C.
    Mackean, M.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S170 - S170
  • [29] Clinical application of the experimental ADL test for patients with cognitive impairment: pilot study
    Yong-Hyun Lim
    Yookyeong Baek
    Soon Ju Kang
    Kyunghun Kang
    Ho-Won Lee
    Scientific Reports, 11
  • [30] Dynamic functional connections in leukoaraiosis patients without cognitive impairment: A pilot study
    Xu, Xingru
    Chen, Yu-Chen
    Yin, Xindao
    Zuo, Taosheng
    Feng, Guangkui
    Xu, Kaixi
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
12345